Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial

Authors

Andreas M. Schmitt (ORCID: https://orcid.org/0000-0002-9568-8164)
Benjamin Kasenda (ORCID: https://orcid.org/0000-0003-0110-8585)
Matthias Briel (ORCID: https://orcid.org/0000-0002-2070-5230)
Stuart McLennan (ORCID: https://orcid.org/0000-0002-2019-6253)
Perrine Janiaud (ORCID: https://orcid.org/0000-0001-7684-8014)
Heinz Läubli (ORCID: https://orcid.org/0000-0002-8910-5620)
Matthias S. Matter (ORCID: https://orcid.org/0000-0002-2005-5266)
Ilaria Alborelli (ORCID: https://orcid.org/0000-0001-7849-3958)
Corinne C. Widmer (ORCID: https://orcid.org/0000-0001-6354-0774)
Lars G. Hemkens (ORCID: https://orcid.org/0000-0002-3444-1432)
Johannes M. Schwenke (ORCID: https://orcid.org/0009-0006-9795-6181)
Mascha Binder (ORCID: https://orcid.org/0000-0003-0663-3004)
Jennifer Hinke

Institutions

University of Bern (CH)
University Hospital of Basel (CH)
Department of Biomedicine Basel (CH)
Innovative Research (United States) (US)
Technical University of Munich (DE)
Stanford University (US)

Publication Details

Journal: BMJ Open
Published: 2025-10-01
DOI: https://doi.org/10.1136/bmjopen-2025-100537
Primary Topic: Cancer Genomics and Diagnostics
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Science Foundation
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Krebsliga Beider Basel

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial

Andreas M. Schmitt, Benjamin Kasenda, Matthias Briel, Stuart McLennan et al.

Oct 1, 2025

BMJ Open

Cancer Genomics and Diagnostics

article

Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial

Andreas M. Schmitt, Benjamin Kasenda, Matthias Briel, Stuart McLennan, Perrine Janiaud, Heinz Läubli, Matthias S. Matter, Ilaria Alborelli, Corinne C. Widmer, Lars G. Hemkens, Johannes M. Schwenke, Mascha Binder, Jennifer Hinke

October 1, 2025article en

Abstract

No abstract available for this paper.

BMJ OpenVol. 15(10)

University of Bern (CH), University Hospital of Basel (CH), Department of Biomedicine Basel (CH), Innovative Research (United States) (US), Technical University of Munich (DE), Stanford University (US)

National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Krebsliga Beider Basel

Openalex Percentile: Top 61%

Cancer Genomics and Diagnostics

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trial — Andreas M. Schmitt, Benjamin Kasenda, et al. · BMJ Open (2025) | TGRS Research Map | TGRS